输尿管下段结石ESWL后应用坦索罗辛临床观察

目的 探讨坦索罗辛在输尿管下段结石ESWL后辅助排石的效果.方法 110例输尿管下段结石患者随机分为两组,对照组52例,ESWL后给予抗感染,口服肾石通4 g Bid;治疗组58例,ESWL后给予抗感染,口服坦索罗辛0.4 mg Qd.每例患者治疗观察期不超过2周.结果 2周内结石排出率,对照组为38.5%（20/52）,治疗组为75.9%（44/58）,两组比较差异有统计学意义（P ＜ 0.05）.结论 ESWL后联合应用坦索罗辛可有效提高排石率.

Clinical observation of applying tamsulosin after ESWL for lower ureteral calculus

Objective To investigate the assisting effectiveness of tamsulosin in discharging lower ureteral calculus after ESWL. Methods One hundred and ten patients with lower ureteral calculus were randomly assigned into two groups. The control group （52 cases） was given anti-inflammatory treatment and oral administration of Shenshitong, 4 g twice a day, after ESWL; while the treatment group （58 cases） oral administration of tamsulosin 0.4 mg once-daily be- sides anti-inflammatory treatment. The observation period of each patient was no more than two weeks. Results During two weeks, the calculus discharging rate of control group and treatment group was respectively 38.5% （20/52） and 75.9% （44/58） with statistically significant difference （P 〈 0.05）. Conclusion Combining application of tamsulosin after ESWL can effectively improve the calculus discharging rate.